Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06849817 · ClinicalTrials.gov registry record · NA

Protein and Exercise for Postmenopausal Women's Wellbeing

A NA study of Postmenopausal, sponsored by University of Arkansas, Fayetteville.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
2
Study locations

NCT06849817: Recruiting NA study of Postmenopausal, sponsored by University of Arkansas, Fayetteville.

NCT06849817 is a NA study of Postmenopausal that is actively recruiting participants, run by University of Arkansas, Fayetteville. The registered enrollment target is 90 participants, below the 131-participant average among 9 other Postmenopausal trials with a reported enrollment target (31% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06849817, a NA study of Postmenopausal, is actively recruiting participants, sponsored by University of Arkansas, Fayetteville.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to learn if consuming a higher protein diet that includes one serving of beef each day, in combination with resistance exercise, improves wellbeing in postmenopausal women. It will also tell us about how higher protein intake changes body composition and blood values related to health. The main questions it aims to answer are: * Does higher protein intake combined with resistance training improve mood and sleep in postmenopausal women? * What other health benefits to postmenopausal women experience when the follow a higher protein diet and participate in resistance exercise? Researchers will compare three groups 1) postmenopausal women living their daily lives as usual, 2) postmenopausal women consuming a higher protein diet, and 2) postmenopausal women consuming a higher protein diet and participating in resistance training. Participants will: * Consume a higher protein diet for 16 weeks * Participate in an at-home resistance training for 16 weeks * Keep a diary of their food intake, sleep habits, and mood * Have health assessments every 4 weeks

Primary Outcome

Sleep quality and duration will be assessed objectively via an ActiGraph triaxial wrist accelerometer GT9X Link (ActiGraph, LLC, Pensacola, FL, USA), a validated method of sleep assessment. Each participant will wear an ActiGraph monitor on the non-dominant wrist for 24 hours/day for seven days (except when bathing or involved in water activities) prior to the start of the intervention and every four weeks throughout the intervention. Accelerometers will be fitted securely on each participant's

Conditions Studied

Interventions

  • OTHER Diet - higher protein
  • BEHAVIORAL Physical activity and resistance training

Study Locations (2)

Arkansas

  • Don tyson Center for Agricultural Sciencers - Fayetteville
  • University of Arkansas - Fayetteville

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2024-10-01
Est. Completion 2026-06-30
Phase NA

What NCT06849817 shows while recruiting

NCT06849817 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 131-participant average among 9 other Postmenopausal trials with a reported enrollment target (31% lower).

The record links to 1 condition, with Postmenopausal appearing as the primary indexed condition, and to 2 interventions - of which Diet - higher protein is the first listed.

NCT06849817 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT06849817 about?

NCT06849817 is a clinical study titled "Protein and Exercise for Postmenopausal Women's Wellbeing". The goal of this clinical trial is to learn if consuming a higher protein diet that includes one serving of beef each day, in combination with resistance exercise, improves wellbeing in postmenopausal women. It will also tell us about how higher protein intake changes body composition and blood valu...

What is the current status of trial NCT06849817?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2024-10-01. Estimated completion is 2026-06-30.

What conditions does trial NCT06849817 study?

This clinical trial studies the following conditions: Postmenopausal.

What interventions are being tested in trial NCT06849817?

The interventions under investigation include: Diet - higher protein (OTHER), Physical activity and resistance training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06849817?

This trial is sponsored by University of Arkansas, Fayetteville, which has 25 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06849817 being conducted?

This trial has 2 study locations across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postmenopausal

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06849817's enrollment target sits among peer trials

90 4th of 9 higher than 6 of 9 other Postmenopausal trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Postmenopausal trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06849817, the US trial registry maintained by the National Library of Medicine. NCT06849817 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.